Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO

Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering....

Redirecting to full article...